HIPEC & Cytoreductive Surgery
Hyperthermic Intraperitoneal Chemotherapy with cytoreductive surgery — curative treatment for peritoneal surface malignancies.
What is HIPEC?
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a specialised cancer treatment where heated chemotherapy is delivered directly into the abdominal cavity during surgery. It is combined with Cytoreductive Surgery (CRS) — removal of all visible cancer from the peritoneal surface.
Who benefits from CRS–HIPEC?
- Pseudomyxoma peritonei (PMP)
- Peritoneal mesothelioma
- Colorectal cancer with peritoneal metastases (selected)
- Ovarian cancer (selected)
- Gastric cancer with limited peritoneal disease
How it works
The surgical team first removes all visible cancer (CRS), which can take 6–12 hours. Then heated chemotherapy at 42°C is circulated through the abdomen for 60–90 minutes. The heat enhances drug penetration and directly kills residual microscopic cancer cells.

Frequently Asked Questions
Answers to the most common questions about HIPEC & Cytoreductive Surgery.
What is the difference between HIPEC and regular chemotherapy?
Regular chemotherapy is given intravenously and reaches all parts of the body. HIPEC delivers high-dose heated chemotherapy directly into the abdomen during surgery, achieving concentrations 20–1000 times higher at the peritoneal surface with much less systemic toxicity.
How long does CRS–HIPEC take?
The combined operation typically lasts 8–14 hours. Cytoreductive surgery alone can take 6–12 hours depending on extent of disease, followed by 60–90 minutes of heated chemotherapy perfusion.
Is HIPEC safe?
At experienced HIPEC centres, 30-day mortality is 1–3%. Major complications occur in 20–30% of cases but most are managed successfully. Careful patient selection is critical — HIPEC is not suitable for everyone with peritoneal disease.
How long is recovery?
Hospital stay is typically 10–14 days, often with an ICU stay of 2–3 days initially. Full recovery takes 2–3 months. Most patients return to normal activities by 3–4 months.
Which cancers are most curable with HIPEC?
Pseudomyxoma peritonei has the highest cure rate (80–90% 5-year survival with CRS–HIPEC). Peritoneal mesothelioma and low-grade appendiceal cancers also respond very well. Colorectal cancer with limited peritoneal disease has 5-year survival of 30–40%.
Am I a candidate for HIPEC?
Candidates are carefully selected using PET-CT, laparoscopy, and the Peritoneal Carcinomatosis Index (PCI). Good performance status, limited disease burden, and suitable tumour biology are essential. Dr. Abhishek can assess candidacy from imaging and reports.
What are the side effects of HIPEC?
Side effects include temporary bone marrow suppression, kidney stress, mild hair loss, and general recovery from a long operation. Compared to systemic chemotherapy, HIPEC has fewer long-term side effects because it is given only once.
Is HIPEC available in India?
Yes. CRS–HIPEC is performed at a small number of specialist centres in India. Dr. Abhishek performs HIPEC at BLK-Max Delhi, one of the leading peritoneal surface oncology programs in the country.
What is the cost of HIPEC in India?
CRS–HIPEC in India typically costs ₹6–10 lakh depending on the extent of cytoreduction and hospital category. This is a fraction of Western costs (USD 100,000+). We provide transparent estimates and insurance support.
How do I know if HIPEC is right for me?
Send your PET-CT scan, previous pathology, and any prior surgery reports via our contact form. Dr. Abhishek will personally assess your case and honestly advise whether HIPEC is appropriate.

Meet Dr. Abhishek Aggarwal
Dr. Abhishek Aggarwal is a highly skilled GI & HPB surgeon with over 10 years of experience in managing complex gastrointestinal and hepato-pancreato-biliary diseases, with a special focus on oncological surgery. He currently serves as Associate Director – GI Oncosurgery at BLK-Max Super Speciality Hospital, where he is actively involved in delivering advanced surgical care for GI and HPB malignancies.
He has trained and worked in reputed high-volume centres, gaining extensive expertise in complex oncological procedures and multidisciplinary cancer care. His clinical practice is firmly grounded in scientific, evidence-based medicine, ensuring that patients receive treatment aligned with the latest global standards and research.
OPD Timing: 09:00 AM – 05:00 PM
Contact Dr. Abhishek →